4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-21-007816
Director sold 171,003 shares at an average $149.11 ($25,497,840)
- Director disposed of 1,285,027 shares (other)
- Director acquired 296,161 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bolzon Bradley J PhD Director | 2021-02-19 | Sale | −78,200 | $147.79 | $11,557,069 | 261,634 | I: show line 1 in the form |
| Bolzon Bradley J PhD Director | 2021-02-19 | Sale | −23,276 | $149.24 | $3,473,785 | 238,358 | I: show line 2 in the form |
| Bolzon Bradley J PhD Director | 2021-02-19 | Sale | −38,132 | $150.10 | $5,723,773 | 200,226 | I: show line 3 in the form |
| Bolzon Bradley J PhD Director | 2021-02-19 | Sale | −27,932 | $150.99 | $4,217,461 | 172,294 | I: show line 4 in the form |
| Bolzon Bradley J PhD Director | 2021-02-19 | Sale | −3,463 | $151.82 | $525,752 | 168,831 | I: show line 5 in the form |
| Bolzon Bradley J PhD Director | 2021-02-19 | Other disposition | −615,607 | 720,481 | I: show line 6 in the form | ||
| Bolzon Bradley J PhD Director | 2021-02-19 | Other acquisition | +158,522 | 158,522 | I: show line 7 in the form | ||
| Bolzon Bradley J PhD Director | 2021-02-19 | Other disposition | −158,522 | 0 | I: show line 8 in the form | ||
| Open-market sales · 171,003 sh · avg $149.11 · $25,497,840 | |||||||
Loading xslF345X03/doc4.xml…